Response to: 'Correspondence on 'Tapering towards DMARD-free remission in rheumatoid arthritis' by Garcia et al

被引：0
|
作者：
van Mulligen, Elise [1 ,2 ]
de Jong, Pascal Hendrik Pieter [1 ]
机构：
[1] Erasmus MC, Rheumatology, Rotterdam, Netherlands
[2] Erasmus MC, Rheumatology, NL-3000 CA Rotterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷 / 01期
关键词：
arthritis; rheumatoid; methotrexate; tumour necrosis factor inhibitors; ultrasonography; glucocorticoids;
D O I：
10.1136/annrheumdis-2020-219293
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] DOES THE PRESENCE OF MRI-DETECTED OSTEITIS AT DIAGNOSIS WITH RHEUMATOID ARTHRITIS LOWERS THE RISK FOR ACHIEVING DMARD-FREE SUSTAINED REMISSION? - RESULTS OF A LONGITUDINAL STUDY
    Burgers, L. E.
    Boeters, D. M.
    Reijnierse, M.
    van der Helm-van Mil, A. H. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1168 - 1168
  • [22] Rheumatoid Arthritis Patients Who Never Use a Biological During Their Disease Course Represent a Subgroup of Patients Likely to Achieve Sustained DMARD-free Remission
    Heutz, Judith
    de Jong, Pascal
    Mil, Annette van der Helm-van
    van Mulligen, Elise
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2542 - 2543
  • [23] Prevalence and predictive factors for DMARD-free remission in RA: Lessons from two large early arthritis cohorts
    van der Woude, D.
    Young, A.
    Brand, R.
    Toes, R. E. M.
    Huizinga, T. W. J.
    Mil, A. H. M. van der Helm-Van
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S760 - S761
  • [24] Response to 'Correspondence to viewpoint 'Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs']js et al
    Buch, Maya H.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (10) : E106 - E106
  • [25] Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review
    Kuijper, T. Martijn
    Lamers-Karnebeek, Femke B. G.
    Jacobs, Johannes W. G.
    Hazes, Johanna M. W.
    Luime, Jolanda J.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (11) : 2012 - 2022
  • [26] Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
    Alfonse T. Masi
    Roy Fleischmann
    Arthritis Research & Therapy, 22
  • [27] Response to: 'Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis' by Boer et al
    Michelsen, Brigitte
    Kvien, Tore K.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (01)
  • [28] Response to: 'Correspondence on 'Onset of rheumatoid arthritis after COVID-19: coincidence or connected?'' by Roongta et al
    Derksen, Veerle F. A. M.
    van der Woude, Diane
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (06) : E137 - +
  • [29] Response to: 'Correspondence on 'EULAR definition of difficult-to-treat rheumatoid arthritis'' by Novella-Navarro et al
    Roodenrijs, Nadia M. T.
    Welsing, Paco M. J.
    van der Goes, Marlies C.
    Jacobs, Johannes W. G.
    van der Heijde, Desiree
    van Laar, Jacob M.
    Nagy, Gyoergy
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03)
  • [30] Response to: 'Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'' by Ruscitti et al
    Baker, Joshua F.
    England, Bryant R.
    Mikuls, Ted R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (05)
12345